Literature DB >> 3004805

The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by ultracentrifugation.

M I Mackness, S D Hallam, T Peard, S Warner, C H Walker.   

Abstract

Using sheep and human serum the relationship between centrifugation time and yield of total lipoprotein, HDL-cholesterol and "A"-esterase in lipoprotein was studied employing different centrifuge rotors. More rapid separation of these components was obtained with a vertical rotor than with an angled rotor. The procedures commonly employed for lipoprotein separation gave low yields of lipoprotein "A"-esterase and HDL-cholesterol. The separation of sheep serum "A"-esterase into the lipoprotein fraction was not in phase with that of HDL-cholesterol and the pattern of separation was different from that in human serum. These results provide further evidence that serum "A"-esterase activity is associated with different species of HDL-particle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004805     DOI: 10.1016/0305-0491(85)90506-1

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  14 in total

1.  Purification and characterization of paraoxon hydrolase from rat liver.

Authors:  L Rodrigo; F Gil; A F Hernandez; A Marina; J Vazquez; A Pla
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis.

Authors:  Arkaitz Mucientes; Benjamín Fernández-Gutiérrez; Eva Herranz; Luis Rodriguez-Rodriguez; Jezabel Varadé; Elena Urcelay; José Ramón Lamas
Journal:  Clin Rheumatol       Date:  2018-12-26       Impact factor: 2.980

3.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

4.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

5.  Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.

Authors:  A F Hernandez; A Pla; A Valenzuela; F Gil; H P Hougen; E Villanueva
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

6.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 7.  "A" esterases and their role in regulating the toxicity of organophosphates.

Authors:  C H Walker; M I Mackness
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

8.  Multiple forms of sheep serum A-esterase activity associated with the high-density lipoprotein.

Authors:  M I Mackness; C H Walker
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

9.  Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.

Authors:  Graziella E Ronsein; Gissette Reyes-Soffer; Yi He; Michael Oda; Henry Ginsberg; Jay W Heinecke
Journal:  Mol Cell Proteomics       Date:  2015-12-14       Impact factor: 5.911

10.  Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Circ Cardiovasc Genet       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.